Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Certain cancer immunotherapy drugs may increase risk for rheumatic disease

Cancer Immunotherapy May Induce Arthritis, Sicca Syndrome

0
Findings with ipilimumab (anti-CTLA-4) and/or nivolumab (anti-PD-1) for solid tumors
Family-reported quality of end-of-life care is significantly better for patients with cancer or dementia than for patients with other chronic conditions

End-of-Life Care Received Varies Based on Type of Disease

0
Cancer and dementia patients get more access to palliative care
The use of patient navigators improves cancer screening rates among low-income and ethnic minority patients

Use of Patient Navigators Improves Cancer Screening Rates

0
Navigators particularly helpful for low-income and ethnic minority patients
Three cases of primary clear cell sarcoma of the head and neck have been described in three male patients

Report Describes Primary Clear Cell Sarcoma of Head, Neck

0
Three cases described in males on scalp, face, tongue; all had nested tumors with fibrous septae

American Society of Clinical Oncology, June 3-7

0
The 52nd Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology was held...
Daratumumab (Darzalex)

ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious

0
Response rate doubled for patients with relapsed or refractory multiple myeloma
Three-quarters of young or middle-aged Americans with terminal cancer receive aggressive treatment during the last month of their lives

ASCO: Aggressive Treatment Common in Terminal CA Patients

0
Three in four of young or middle-aged patients get aggressive therapies in last months of lives
Young children with high-risk neuroblastoma have improved survival when they receive two autologous stem-cell transplants rather than one

ASCO: Double ASCT Beneficial in High-Risk Neuroblastoma

0
Tandem treatments might give survival edge to children with neuroblastoma
A new blood-based "liquid biopsy" could be a groundbreaking alternative to the traditional biopsy

ASCO: ‘Liquid Biopsy’ Shows Promise for Tumor Surveillance

0
Guardant360 predicts cancer DNA mutations and could help tailor treatments to avoid drug resistance
Cancer survivors in the United States reached record numbers this year -- 15.5 million -- and the American Cancer Society predicts they'll total more than 20 million in another decade. The report

15.5 Million Americans Now Surviving Cancer

0
But better tools needed to support their long-term recovery, researchers say